Referenties
[1]
Diagnostics and Statistical Manual of Mental Disorders. Fifth Edition. 2013.
[2]
Gutiérrez-Rojas L et al. Braz J Psychiatrt 2020; 42(6): 657–672.
[3]
Bromet E et al. BMC Med 2011; 9: 90.
[4]
Vandeleur CL et al. Psychiatry Res 2017; 250: 50–58.
[5]
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Lancet 2018; 392: 1789-858.
[6]
Lasserre AM et al. J Affect Disor 2016; 189: 17–24.
[7]
Handley T et al. Int J Environ Res Public Health 2018; 15: 928.
[8]
Fiorillo A et al. Eur Psych. 2011; 26(S2): 625. Published online. DOI: 10.1016/S0924-9338(11)72331-8.
[9]
OECD Health at a Glance: Europe 2018. Accessible at: https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-europe-2020_82129230-en. Accessed September 2022.
[10]
European Medicines Agency. Guideline on clinical investigation of medicinal products in the treatment of depression. 2013. EMA/CHMP/185423/2010. Rev. 2. 2013. Accessed September 2022.
[11]
Cleveland Clinic. Treatment-Resistant Depression 2023.
